Search
for
Sort by
Research 811–840 of 1000+
- Pharmacokinetic studies of minoxidil
- Preparation of finasteride capsules-loaded drug nanoparticles: formulation, optimization, in vitro, and pharmacokinetic evaluation
- Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5α-reductases: determinants for different in vivo activities of GI198745 and finasteride in the rat 3 3Abbreviations: r5AR1, rat 5α-reductase 1; r5AR2, rat 5α-reductase 2; and DHT, dihydrotestosterone.
- Rapid determination of finasteride in human plasma by UPLC–MS/MS and its application to clinical pharmacokinetic study
- A rapid, simple, specific liquid chromatographic–electrospray mass spectrometry method for the determination of finasteride in human plasma and its application to pharmacokinetic study
- Pharmacokinetic Interaction between Finasteride and Terazosin, but not Finasteride and Doxazosin
- Pharmacokinetic and Therapeutic Dose Comparison of Diane-35 and IVF-C Inj 5000 IU in Common Quail
- BIO-ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF FINASTERIDE, TADALAFIL, AND ITS APPLICATION TO PHARMACOKINETIC STUDIES IN RAT PLASMA BY USING LC-MS/MS
- Pharmacokinetic study in hairless rat after topical application of finasteride: single and repeated dose
- A Pharmacogenetic Survey of Androgen Receptor (CAG)N and (GGN)N Polymorphisms in Patients Experiencing Long Term Side Effects after Finasteride Discontinuation
- Development of optimized self-nanoemulsifying lyophilized tablets (SNELTs) to improve finasteride clinical pharmacokinetic behavior
- Oral Testosterone in Oil: Pharmacokinetic Effects of 5 Reduction by Finasteride or Dutasteride and Food Intake in Men
- Virtual Bioequivalence Assessment of Ritlecitinib Capsules with Incorporation of Observed Clinical Variability Using a Physiologically Based Pharmacokinetic Model
- Assessment of the Pharmacokinetic -Pharmacodynamic Interaction Between Terazosin and Finasteride
- Development and Qualification of a Physiologically Based Pharmacokinetic Model of Finasteride and Minoxidil Following Scalp Application
- In vivo Pharmacokinetic Interactions of Finasteride and Identification of Novel Metabolites
- A population pharmacokinetic model for individualized regimens of finasteride according to CYP3A5 genotype and liver function
- 3P's (Pharmacokinetic, Pharmacodynamic, and Pharmacogenomic) of Valproate: What's New?
- A Study on the Clinical Profile and Pharmacogenetics of Methotrexate Treatment in Patients with Rheumatoid Arthritis.
- Effect of finasteride particle size reduction on its pharmacokinetic, tissue distribution and cellular permeation.
- Preparation of finasteride capsules-loaded drug nanoparticles: formulation, optimization, in vitro, and pharmacokinetic evaluation
- Novel 5α-Reductase Inhibitors: Synthesis, Structure−Activity Studies, and Pharmacokinetic Profile of Phenoxybenzoylphenyl Acetic Acids
- Cloning of the human phenol sulfotransferase gene family: three genes implicated in the metabolism of catecholamines, thyroid hormones and drugs
- Poor Therapeutic Response in Female Pattern Hair Loss: Mechanisms and a Practical Framework for Clinical Management
- Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies
- Genomic Markers and Personalized Medicine in Androgenetic Alopecia: A Comprehensive Review
- Medical Treatment of Alopecia
- Use of chemotherapy during human pregnancy
- Cyclosporin A: a new drug in the field of canine dermatology
- Experimental, molecular docking investigations and bioavailability study on the inclusion complexes of finasteride and cyclodextrins